Phenol block for spasticity management
DOI:
https://doi.org/10.11606/issn.2317-0190.v15i3a102949Keywords:
Phenol, Muscle Spasticity, Nerve BlockAbstract
Peripheral blocks with botulinum toxin (BoTN) and phenol are the treatment of first choice in the management of focal spasticity. This review will focus on phenol blocks, presenting some historical aspects, principles of action, main indications and the clinical applicability of this substance. The purpose of this review is to remind that, when its indications are respected, phenol has shown a good balance between efficacy and safety. Since it is an extremely low-cost drug, phenol should be considered as the ideal agent for large-scale use in resource-poor rehabilitation centres.
Downloads
References
Lianza S. Espasticidade: conceitos atuais baseados em evidências científicas. São Paulo: SPMFR/SBMFR; 2004.
Calderón-González R, Calderón-Sepúlveda RF. Clinical treatment (non surgical) of spasticity in cerebral palsy. Rev Neurol. 2002;34(1):1-6.
Jozefczyk PB. The management of focal spasticity. Clin Neuropharmacol. 2002;25(3):158-73.
Teive HAG, Zonta M, Kumagai Y. Treatment of spasticity: an update. Arq. Neuro-Psiquiatr. 1998;56(4):852-8.
Ade-Hall RA, Moore AP. Botulinum toxin type A in the treatment of lower limb spasticity in cerebral palsy. Cochrane Database Syst Rev. 2000;(2):CD001408.
On AY, Kirazli Y, Kismali B, Aksit R. Mechanisms of action of phenol block and botulinus toxin Type A in relieving spasticity: electrophysiologic investigation and follow-up. Am J Phys Med Rehabil. 1999;78(4):344-9.
Casalis MEP. Reabilitação - espasticidade. Rio de Janeiro: Atheneu; 1990.
Walsh NE, Rogers JN. Injection procedures. In: Delisa JA, editor. Physical Medicine and Rehabilitation: principles and practice. 4th edition. Philadelphia: Lippincott Williams and Wilkins; 2004. p.311-60.
Downloads
Published
Issue
Section
License
Copyright (c) 2008 Acta Fisiátrica
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
